$10.5 million fine for Las Vegas Strip resort is 2nd-highest in state history
It's a heavy price for what Nevada Gaming regulators regard as a grave situation at a Las Vegas Strip casino. The complaint originally filed in August detailed two illegal bookmakers operating with impunity, gambling millions as anti-money laundering (AML) regulations went by the wayside. Casino hosts and upper management allowed or ignored the situation, resulting in a culture of money laundering.
Only Wynn Resorts has paid a higher fine — $20 million assessed in February 2019 for failing to properly investigate sexual harassment allegations against former CEO Steve Wynn.
On Wednesday, Resorts World announced that it was laying off around 50 employees. If one thing was clear from Thursday's hearing, the company's AML program wasn't included in the layoffs. Resorts World has redoubled its efforts and has set a goal to be an industry leader.
Commissioners discussed the scale of the penalty before voting to approve the settlement, with Commissioner Abbi Silver recusing herself from participating because of a longtime friendship with Scott Sibella, who was in charge at Resorts World when the events spun out of control. Sibella lost his gaming license.
'Personally, I feel that the fine is on the low side,' Commissioner Rosa Solis-Rainey said during Thursday's hearing.
'We've seen a larger fine for things that weren't on the gaming floor, and not over the same period of time,' Commissioner Brian Krolicki said.
'At the end of the day, the folks who made those decisions, allowed those decisions, who were in the C-suite, who were on the floor, who were in the pit, who were the hostesses … they're gone,' Krolicki said.
PENDING-Stipulation-for-Settlement-24-04-ComplaintDownload
The amount of the fine was disclosed a week ago, and became final with Thursday's vote. Resorts World has two days to pay the state.
The investigation into Resorts World started as regulators examined the activities of Mathew Bowyer, a Southern California man who pleaded guilty to running an illegal gambling business in August 2024. Bowyer took bets from the interpreter who worked for Los Angles Dodgers superstar Shohei Ohtani in a case that received massive media coverage.
Bowyer's wife, Nicole, was an independent contractor at Resorts World, working as a casino host for customers including her husband, according to statements during Thursday's commission meeting.
The investigation also involved Damien Forbes, a patron when the resort opened in 2021 who was known to be an illegal bookmaker by a casino host. That host even sent business to LeForbes, according to the August complaint.
Names of the hosts were not released by gaming regulators.
The allegations against Resorts World were 'particularly egregious,' according to Darlene Caruso, Nevada's chief deputy attorney general. She outlined the terms of the settlement:
Resorts World will pay a $10.5 million fine, due to the state within two days
Conditions have been attached to the company's gaming license, specifying it will retain core elements of its recently revised AML program, including ongoing updates and an annual review.
Certain AML documents must be retained for at least five years.
Within 60 days, Resorts World will assign all independent agents an AML training module.
In two years, a internal audit and report are required. If regulators are not satisfied, an external audit will take place.
Resorts World will report any notice of a criminal investigation to Nevada gaming authorities.
The company will retain at least its current AML staffing levels.
Nevada gaming regulators reserve the right to bring additional actions against Resorts World.
Major changes in leadership have already taken place since regulators got involved. A board of directors over the resort has been established — a big change for corporate owners Genting Berhad. That board includes Chair Jim Murren, former CEO at MGM Resorts International, former Nevada Gov. Brian Sandoval, former Nevada Gaming Control Board Chair A.G. Burnett, Genting Berhad executive Kong Han Tan, and executive Michelle DiTondo.
The company has a new CEO, a new COO/CFO and a new position for a compliance officer, which Resorts World is actively working to hire.
The company has trained 1,100 employees and is working with UNLV to create a customized gaming compliance program for executives and key employees.
Krolicki said this should send another signal to gaming operators.
'I also believe this is a clarion call up and down that street that aml, compliance, audit, all of these things we talk about all the time, we really mean it. It's easy to say, but it's harder to do,' he said.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
BTIG Raises Syndax Pharmaceuticals (SNDX) PT to $56 Following Strong Q2 Revenue from Revuforj, Niktimvo
Syndax Pharmaceuticals Inc. (NASDAQ:SNDX) is one of the best small cap stocks with biggest upside potential. On August 5, BTIG analyst Justin Zelin raised the firm's price target on Syndax to $56 from $43, while maintaining a Buy rating on the shares. The company delivered strong Q2 2025 results, with Revuforj and Niktimvo posting breakout commercial performance that exceeded internal and external expectations for Q2 and surpassed benchmarks set by precedent AML launches. The company's total revenue for the quarter was $38 million. This was comprised of $28.6 million in net product revenue from Revuforj, which was a 43% sequential increase, and $9.4 million in collaboration revenue from Niktimvo. Niktimvo, which is co-commercialized with Incyte, generated $36.2 million in net revenue during its first full quarter since its late January 2025 launch. A scientist in a laboratory testing a monoclonal antibody for the treatment of cancer. Syndax is advancing its pipeline and regulatory milestones. The US FDA granted Priority Review for the supplemental New Drug Application/sNDA for Revuforj to treat relapsed or refractory (R/R) mutant NPM1 acute myeloid leukemia/AML with a target action date of October 25 this year. If approved, it would be the first therapy for this indication. Additionally, the company is conducting multiple trials for both Revuforj and Niktimvo in new indications and in combination with other therapies. Syndax Pharmaceuticals Inc. (NASDAQ:SNDX) is a commercial-stage biopharmaceutical company that develops therapies for the treatment of cancer. While we acknowledge the potential of SNDX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Forbes
4 days ago
- Forbes
As Scammers Up Their Fraud Game, Consumers, Banks, And Law Enforcement Must Respond
Technology may make fraud easier—thanks to social media—but it may also be the way to stop it. getty Fraud schemes and scammers are increasingly making headlines, with some scratching their heads to figure out why—and how to stop it. A recent study conducted by BioCatch, a global company focused on solving next-generation digital identity challenges through examining behavioral biometrics, might offer some clarity. The survey found that 81% of Americans cited artificial intelligence (AI) as contributing to more sophisticated financial crimes, with social media (75%) and the dark web (73%) playing key roles in the equation. That data was pulled from a BioCatch survey of 800 senior fraud, anti-money laundering (AML), and risk and compliance professionals across 17 countries on five continents. The survey was an attempt to better understand how financial institutions are fighting fraud and financial crime, the impact of emerging technologies on the dark economy, and the level of collaboration among competing institutions, law enforcement, and governments. The impact on consumer wallets is significant. Nasdaq's Global Financial Crime Report estimates that $3.1 trillion in illicit funds moved through the world's financial system in 2023. Scams and fraud added up to $485.6 billion in projected losses. Of those moves, U.S. victims have taken a beating: the U.S. ranks second globally for major fraud losses. That likely explains why, in the U.S., almost all of those surveyed agree that combating activities that encompass the dark economy is important. So what can be done to stop it? Many professionals aren't quite sure. Most of those surveyed (83%) believe that their financial institutions are winning the fight against fraudsters, while only 56% believe their individual efforts have an impact on combating financial crime. That may not tell the whole story. Matt O'Neill, a former Secret Service agent, says there's a real disconnect between losses and what banks are prioritizing. Fraud losses hit individuals in the pocketbook, not banks. The banks aren't materially affected, and there hasn't been a real push to pivot from the status quo. While U.S. banks may trust technology, they don't trust each other, O'Neill explains. That means there's no meaningful sharing of information. That's a break from behaviors other countries where statistics suggest that when other countries share at scale, their losses are decreasing. (Part of the reluctance to share information may come from consumers. While 32% of those surveyed in the U.S. consider data privacy regulation as one of the main inhibitors to sharing data with other banks, 30% worry about the potential for misuse. These numbers are higher than global averages.) Nearly all (93%) of those surveyed consider their organization to be effective in fighting financial crime, and four in five of those surveyed say their banks have incorporated behavioral analysis into their technology stack to detect financial crime. Those numbers may sound impressive, but O'Neill says that criminal networks are actually outpacing banks while banks are still playing catch-up. The Role Of Law Enforcement Despite an increase in reports of fraud, law enforcement agencies are reaching out to banks less often. That means there may not be a unified effort to stop scammers. And, tellingly, it makes a real difference where the fraud happens—even when banks do contact local law enforcement, not all law enforcement have the means, ability, and time to respond to sophisticated scams and attacks. The majority of Americans working in financial crime prevention believe that law enforcement should do more when a Suspicious Activity Report (SAR) is filed. By law, national banks are required to report known or suspected criminal offenses, transactions over $5,000 suspected to involve money laundering or violations of the Bank Secrecy Act (BSA), and transactions of $25,000 or more involving a criminal violation, even if no suspect is identified. The level of follow-up from those SARs may be inconsistent across banks and across demographics. Banks also report that they don't receive regular contact from law enforcement about their investigations into criminal activity. When it does happen, the contact tends to be less frequent than on a monthly basis. Customer-Focused Communications On the consumer side, banks and other financial institutions have tried to boost awareness about the potential for fraud, often by creating awareness campaigns. But Seth Ruden, Senior Director of Global Advisory at BioCatch, notes that can only go so far. 'Social engineering is so compelling,' he says, and efforts to combat it are not as effective as the tactics exercised by bad actors. Social engineering is a form of manipulation which relies on human psychology to direct behaviors. In this context, scammers may spend significant resources to convince potential victims to take certain steps like revealing personally identifiable information or transferring assets to a third party. To combat that manipulation, institutions need new controls to fight scammers, including those to alert potential victims. Oftentimes, banks may notice the potential fraud before the victim does, or before third parties do. But it may be too difficult to break the spell. Creating some friction at the consumer level could delay funds from being released. That, combined with the sharing of information between financial institutions, could be a difference maker. When funds leave an account, there's a narrow window of time before they're captured at the receiver bank. 'What if,' Ruden asks, 'we could connect in real time?' That could present an opportunity to stop or mitigate the damage. O'Neill agrees, suggesting that while precision analytics can be a real game-changer for banks, additional resources—including a human touch—can also make a difference. For example, when a potential victim is determined to send funds to a new payee, like a new romantic interest, asking the right questions could result in a pause in activity. Asking a question as simple as, 'Why would send money to someone you have never met before?' could trigger a conversation that could result in enough information to reveal that the payment is very suspicious. The key, of course, is to create friction without making it a competitive disadvantage. That, says Ruden, requires resources. Those on the other side of the equation—the fraudsters—are sophisticated actors and are willing to dedicate time and money to see a scam through. Fighting will require the same dedication from financial institutions. But it may well be the case that those spends are welcome since nearly two-thirds of those surveyed say they'd like to increase their investment in technology (those in the U.S. said so at a much higher rate than the global average). What Can Consumers Do? So much of fighting fraud still rests with the consumer. So, what can consumers do to protect themselves? O'Neill is quick to offer his advice, emphasizing, 'Never ever send money to anyone that you've never seen or touched before.' If you make a mistake, 'The cavalry isn't coming,' he says, noting that the likelihood is slim to recover the funds. 'There isn't a magic button to recover those funds,' so it's important to think it through. 'If it's going to hurt you to lose it, don't send it,' he warns. Ruden says that it's going to take a technology revolution to protect consumers. He thinks such a move should be welcomed, noting that it's in the interest of financial institutions and fiduciaries to help protect their customers. Some do a better job than others—and those are the organizations that consumers should seek out. 'Look for a culture of protection,' he advises, saying that consumers should keep an eye out for institutions that place an emphasis on fraud-fighting. This can mean existing trained fraud prevention teams or otherwise demonstrating a commitment to protect consumers through their business practices. Tax Rules For Losses If you are a victim of a scam, while you may not be able to recover your losses, you may be entitled to tax relief. Earlier this year, the IRS Office of Chief Counsel released a memo providing clarification on the deductibility of theft losses for scam victims. The memo was welcome for taxpayers who were confused about limits resulting from the Tax Cuts and Jobs Act (TCJA) made another tweak. Under the TCJA, for the tax years 2018 to 2025, personal casualty and theft losses are deductible only to the extent that the losses are attributable to a federally declared disaster. The One Big Beautiful Bill Act made the limits to losses permanent, with one exception: it has been expanded to include state-declared disasters. That means the theft loss deduction is still available for businesses and individuals who incur losses in transactions entered into for profit. There is no statutory definition of "a transaction entered into for profit." However, courts have determined that to meet the criteria, a primary profit motive is required. Next Steps As scammers develop new schemes to steal money and information from consumers (you can read about a new one here), the commitment to fraud prevention must evolve even faster. Understanding what kinds of scams exist and how they operate, as well as the roles that consumers, law enforcement, and financial institutions can play in mitigation and prevention, are all key. That means that education will continue to be a big part in stopping scammers. You can read the Biocatch global survey here. Forbes FBI Warns Scam Victims To Be On The Lookout For Fake Law Firms Offering To Help Recover Losses By Kelly Phillips Erb Forbes IRS Issues Warnings On Tax Scams Driven By Bad Advice Often Found On Social Media By Kelly Phillips Erb Forbes Some Scam Victims May Be Able To Deduct Related Losses On Their Tax Returns By Kelly Phillips Erb
Time Business News
4 days ago
- Time Business News
Next-Generation Approaches to Hematologic Malignancies
Hematologic malignancies are cancer that affect blood, bone marrow, and lymphatic systems including leukemia, lymphoma and multiple myeloma. These cancers disrupt normal blood cell production and immune function. The growth of the hematologic malignancy market is inspired by increasing the prevalence of global cancer, increasing target remedies and immunotherapy, progression in clinical technologies and expanding research in individual medicine. Additionally, increasing awareness, better healthcare infrastructure, and oncology contribute to more investment market expansion in drug development. Key Growth Drivers and Opportunities Increasing the Prevalence of Global Cancer: The increasing global spread of cancer greatly enhances the growth of the market of hematologic malignancies, as blood -related cancer, such as leukemia, lymphoma and multiple myeloma, become a large part of cancer worldwide. As more individuals are affected by these conditions, there is an increasing demand for accurate diagnosis, advanced treatment options and long -term disease management solutions. In cases, this increase encourages drug companies and research institutes to invest in innovative remedies such as targeted treatment, immunotherapy and CAR-T cell therapy. Additionally, high cancer phenomena motivate governments and healthcare systems to increase screening programs and to reach oncology. Challenges Hematologic malignancies markets face several borders, including high cost of advanced treatments such as car-T cell treatment and targeted drugs, which can restrict access to patients in low- and moderate-income areas. Complex regulatory approval, long clinical testing procedures, and severe side effects or ability to resist also face significant challenges. Additionally, limited availability of specialized clinical equipment and lack of efficient health care professionals in some fields obstruct timely and accurate diagnosis, overall treatment affects results and slows down market development. Innovation and Expansion Kyowa Kirin and Kura Oncology Collaborate to Create Ziftomenib for Acute Leukemias In November 2024, in order to develop and market ziftomenib, Kura's selective oral menin inhibitor, which is being researched for the treatment of patients with acute myeloid leukemia (AML) and other hematologic malignancies, Kura Oncology, Inc. and Kyowa Kirin Co., Ltd. announced they have formed a global strategic partnership. Kura will get USD 330 million up front as part of the deal, and it anticipates receiving up to USD 420 million in near-term milestone payments, including one when ziftomenib is introduced in the monotherapy relapsed/refractory (R/R) context. Merck Launched Phase III Trials for Novel Treatments for Blood Disorders and Cancer In January 2024, With the start of pivotal Phase III studies for four new candidates for solid tumors and hematologic malignancies, Merck's strong oncology and hematology portfolio is progressing. Essential thrombocythemia (ET), small lymphocytic lymphoma (SLL), chronic lymphocytic leukemia (CLL), non-small cell lung cancer (NSCLC), some patients with endometrial carcinoma who have already received treatment, and metastatic castration-resistant prostate cancer (mCRPC) are among the conditions for which the company announced active enrollment for investigational medications. The firm is committed to ongoing research to broaden our portfolio of oncology treatments in order to continue addressing unmet needs in cancer care. The company has a rich history of transforming groundbreaking science into medicines that save and enhance lives worldwide. Inventive Sparks, Expanding Markets The key players operating the hematologic malignancies market includes, Johnson & Johnson Services Inc., Pfizer Inc., Novartis AG, AbbVie Inc., GlaxoSmithKline PLC., Bristol-Myers Squibb Company, Glenmark Pharmaceuticals Inc., Celgene Corporation, F. Hoffman-La Roche Ltd., Takeda Pharmaceutical Company Limited., and others. About Author: Prophecy is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business. TIME BUSINESS NEWS
